282 related articles for article (PubMed ID: 33099992)
1. Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate.
Das AB; Smith-Díaz CC; Vissers MCM
Haematologica; 2021 Jan; 106(1):14-25. PubMed ID: 33099992
[TBL] [Abstract][Full Text] [Related]
2. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic deregulation in myeloid malignancies.
Meldi KM; Figueroa ME
Transl Res; 2015 Jan; 165(1):102-14. PubMed ID: 24813528
[TBL] [Abstract][Full Text] [Related]
4. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
Wen S; Wang J; Liu P; Li Y; Lu W; Hu Y; Liu J; He Z; Huang P
Cancer Lett; 2018 Jan; 413():35-45. PubMed ID: 29069576
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulators and their impact on therapy in acute myeloid leukemia.
Pastore F; Levine RL
Haematologica; 2016 Mar; 101(3):269-78. PubMed ID: 26928248
[TBL] [Abstract][Full Text] [Related]
6. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic therapies in acute myeloid leukemia: where to from here?
Fennell KA; Bell CC; Dawson MA
Blood; 2019 Nov; 134(22):1891-1901. PubMed ID: 31697822
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations in acute myeloid leukemias.
Mehdipour P; Santoro F; Minucci S
FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
[TBL] [Abstract][Full Text] [Related]
9. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
Parfett CL; Desaulniers D
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
[TBL] [Abstract][Full Text] [Related]
10. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.
Pan D; Rampal R; Mascarenhas J
Blood Adv; 2020 Mar; 4(5):970-982. PubMed ID: 32150613
[TBL] [Abstract][Full Text] [Related]
11. Role of epigenetic in leukemia: From mechanism to therapy.
Liu XL; Liu HQ; Li J; Mao CY; He JT; Zhao X
Chem Biol Interact; 2020 Feb; 317():108963. PubMed ID: 31978391
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.
Reikvam H; Hoang TT; Bruserud Ø
Expert Rev Hematol; 2015 Jun; 8(3):315-27. PubMed ID: 25901742
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
Wouters BJ; Delwel R
Blood; 2016 Jan; 127(1):42-52. PubMed ID: 26660432
[TBL] [Abstract][Full Text] [Related]
15. The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia.
Travaglini S; Gurnari C; Antonelli S; Silvestrini G; Noguera NI; Ottone T; Voso MT
Front Cell Dev Biol; 2022; 10():930205. PubMed ID: 35938170
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia.
Przespolewski A; Wang ES
Expert Opin Investig Drugs; 2016 Jul; 25(7):771-80. PubMed ID: 27077938
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Epigenome by Vitamin C.
Young JI; Züchner S; Wang G
Annu Rev Nutr; 2015; 35():545-64. PubMed ID: 25974700
[TBL] [Abstract][Full Text] [Related]
18. Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in
Smith-Díaz CC; Magon NJ; McKenzie JL; Hampton MB; Vissers MCM; Das AB
Front Oncol; 2021; 11():709543. PubMed ID: 34497762
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
McDevitt MA
Semin Oncol; 2012 Feb; 39(1):109-22. PubMed ID: 22289497
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
Kim TK; Gore SD; Zeidan AM
Semin Hematol; 2015 Jul; 52(3):172-83. PubMed ID: 26111464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
